earnings
confidence high
sentiment positive
materiality 0.85
Fulgent Genetics Q3 revenue $227.9M (+124% YoY); raises FY revenue guidance to $930M
Fulgent Genetics, Inc.
- Revenue $227.9M (+124% YoY); core revenue $40.1M (+292% YoY).
- GAAP net income $122.5M ($3.93 diluted EPS); non-GAAP net income $126.3M ($4.05 per share).
- Adjusted EBITDA $167.3M; cash & investments $877.3M as of Sep 30, 2021.
- Full-year 2021 revenue guidance raised to $930M from $800M.
- Billable tests ~2.2M in Q3, more than double Q3 2020.